These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 8698683)
41. Body dysmorphic disorder: diagnosis and approach. Jakubietz M; Jakubietz RJ; Kloss DF; Gruenert JJ Plast Reconstr Surg; 2007 May; 119(6):1924-1930. PubMed ID: 17440376 [TBL] [Abstract][Full Text] [Related]
42. Body dysmorphic disorder in cosmetic surgery patients. Sarwer DB; Crerand CE; Didie ER Facial Plast Surg; 2003 Feb; 19(1):7-18. PubMed ID: 12739178 [TBL] [Abstract][Full Text] [Related]
43. A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder. Saxena S; Winograd A; Dunkin JJ; Maidment K; Rosen R; Vapnik T; Tarlow G; Bystritsky A J Clin Psychiatry; 2001 Jan; 62(1):67-72; quiz 73. PubMed ID: 11235937 [TBL] [Abstract][Full Text] [Related]
44. A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder. Phillips KA; Albertini RS; Rasmussen SA Arch Gen Psychiatry; 2002 Apr; 59(4):381-8. PubMed ID: 11926939 [TBL] [Abstract][Full Text] [Related]
45. Understanding and treating body dysmorphic disorder. Singh AR; Veale D Indian J Psychiatry; 2019 Jan; 61(Suppl 1):S131-S135. PubMed ID: 30745686 [TBL] [Abstract][Full Text] [Related]
47. Body dysmorphic disorder. Castle DJ; Rossell S; Kyrios M Psychiatr Clin North Am; 2006 Jun; 29(2):521-38. PubMed ID: 16650721 [TBL] [Abstract][Full Text] [Related]
48. Recent advances in understanding and managing body dysmorphic disorder. Krebs G; Fernández de la Cruz L; Mataix-Cols D Evid Based Ment Health; 2017 Aug; 20(3):71-75. PubMed ID: 28729345 [TBL] [Abstract][Full Text] [Related]
49. Body dysmorphic disorder. Cotterill JA Dermatol Clin; 1996 Jul; 14(3):457-63. PubMed ID: 8818555 [TBL] [Abstract][Full Text] [Related]
50. Body Dysmorphic Disorder: Clinical Overview and Relationship to Obsessive-Compulsive Disorder. Phillips KA; Kelly MM Focus (Am Psychiatr Publ); 2021 Oct; 19(4):413-419. PubMed ID: 35747292 [TBL] [Abstract][Full Text] [Related]
51. A review of cognitive behavioral and pharmacological treatment of body dysmorphic disorder. Neziroglu F; Yaryura-Tobias JA Behav Modif; 1997 Jul; 21(3):324-40. PubMed ID: 9243958 [TBL] [Abstract][Full Text] [Related]
52. Body dysmorphic disorder: recognizing and treating imagined ugliness. Phillips KA World Psychiatry; 2004 Feb; 3(1):12-7. PubMed ID: 16633443 [TBL] [Abstract][Full Text] [Related]
53. [Results of long-term observation (3-11 years) of patients with dual diagnosis: body dysmorphic disorder and delusional disorder, somatic type]. Rabe-Jabłońska J Psychiatr Pol; 1998; 32(2):143-53. PubMed ID: 9640983 [TBL] [Abstract][Full Text] [Related]
54. Case study: body dysmorphic disorder in adolescents. Phillips KA; Atala KD; Albertini RS J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1216-20. PubMed ID: 7559317 [TBL] [Abstract][Full Text] [Related]
55. Diagnosis and treatment of body dysmorphic disorder in adolescents. Hadley SJ; Greenberg J; Hollander E Curr Psychiatry Rep; 2002 Apr; 4(2):108-13. PubMed ID: 11914171 [TBL] [Abstract][Full Text] [Related]
57. Insight in obsessive compulsive disorder and body dysmorphic disorder. Eisen JL; Phillips KA; Coles ME; Rasmussen SA Compr Psychiatry; 2004; 45(1):10-5. PubMed ID: 14671731 [TBL] [Abstract][Full Text] [Related]
58. Placebo-controlled study of pimozide augmentation of fluoxetine in body dysmorphic disorder. Phillips KA Am J Psychiatry; 2005 Feb; 162(2):377-9. PubMed ID: 15677604 [TBL] [Abstract][Full Text] [Related]